Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS MSCI Canada UCITS ETF hGBP dis
LU1130156596 · LU1130156596 · GBP · domicile Luxembourg
EquityGBP-hedged share classSFDR art. 6
Index tracked: MSCI Canada hedged to GBP Total Return Net
- TER
- 0.36%+ trans. 0.06%
- Fund size
- —
- Tracking difference
- −0.24%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 27 Feb 2015 · costs from the KID as of 26 Aug 2026 · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è gestito in modo passivo e assumerà un'esposizione proporzionale alle componenti del MSCI Canada 100% hedged to GBP Index (Net Return) tramite investimenti diretti in tutti o quasi tutti i titoli che lo compongono e/o mediante l'uso di derivati, in particolare laddove non sia possibile o praticabile replicare l'indice attraverso investimenti diretti o al fine di generare efficienze nell'acquisizione dell'esposizione all'indice. In alcuni casi il comparto potrebbe anche detenere titoli non compresi nell'indice se il gestore del portafoglio lo…
Performance since series start (in euro) — base 100
27 Feb 2015 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +29.7% |
| 3 years | +99.4% |
| 5 years | +100.9% |
| 10 years | +195.6% |
| Since series start | +152.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.74% | 16.38% | 15.52% |
| Max drawdown | −8.07% | −27.88% | −27.88% |
| Sharpe | 1.76 | 0.81 | 0.46 |
| Sortino | 2.54 | 0.98 | 0.58 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1130156596 · LU11301565961
RebalixLU1130156596 · LU1130156596 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +31.94% | +32.21% | −0.27% |
| 2024 | +22.43% | +22.66% | −0.23% |
| 2023 | +11.77% | +11.99% | −0.23% |
| 2022 | −7.59% | −7.36% | −0.23% |
| 2021 | +24.53% | +24.82% | −0.28% |
Distributions · per share, in GBP
Frequency: semi-annual · last 12 months: 0.2961 GBP (1.24% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2961 | — |
| 2025 | 2 | 3.7071 | +19.22% |
| 2024 | 1 | 0.3309 | +2.06% |
| 2023 | 2 | 0.3408 | +2.32% |
| 2022 | 2 | 0.301 | +1.85% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
M490 · Tradegate Exchange
+ 2 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1130156596
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1130156596
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1130156596 · LU11301565962